Respiratory Care Teams Are the MVPs of CF Care
As a person with cystic fibrosis, I’ve formed close-knit relationships with care providers in multiple disciplines. Before my double-lung...
enGene Receives Funding Through Cystic Fibrosis Foundation's Path to a Cure
BOSTON and MONTRÉAL, Oct. 29, 2020 /PRNewswire/ - enGene Inc., a biotechnology company developing non-viral gene therapies for local...
Preclinical Work Supports ELX-02, Potential Treatment for Nonsense Mutations
Eloxx Pharmaceuticals presented preclinical safety and efficacy data supporting ELX-02, its investigational treatment for cystic fibrosis...
Cystic fibrosis (CF) and staphylococcus aureus infections
Staphylococcus aureus (known as staph) is a bacterium that is quite common in the general population. If someone with cystic fibrosis...
New medical trial for Cystic Fibrosis patients helps with medication side effects
The coronavirus pandemic has had a surprising benefit for cystic fibrosis patients. Dr. Perry Brown, with the St. Luke's Idaho Cystic...
IV antibiotics not superior to oral therapy for eradicating P. aeruginosa in cystic fibrosis
Treatment with IV antibiotics, compared with oral therapy, did not achieve sustained eradication of Pseudomonas aeruginosa in a greater...
Treating cystic fibrosis with mRNA therapy or CRISPR
New Rochelle, NY, October 8, 2020--The potential for treating cystic fibrosis (CF) using mRNA therapies or CRISPR gene editing is...
Certain Factors Could Predict Severe Episodes of Coughing Up Blood in CF Patients, Study Says
Factors such as diabetes, a specific type of fungal infection, and previous mild to moderate episodes of hemoptysis, or coughing up...
Calithera Biosciences’ CB-280 Arginase Inhibitor Trial in Progress Poster Presented at the NACFC
SOUTH SAN FRANCISCO, Calif., Oct. 07, 2020 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical stage biotechnology...
Lenabasum Fails to Lessen Exacerbations in CF Patients in Phase 2 Trial
A Phase 2 clinical trial of oral lenabasum in people with cystic fibrosis (CF) failed to meet its primary goal of reducing pulmonary...
